Hongge Liang

<p>Prospect of immunotherapy combined with anti-angiogenic agents in patients with advanced non-small cell lung cancer</p>

Hongge Liang, Mengzhao Wang · Cancer Management and Research · 2019 · 51 citations · Full text

Medicine, Oncology, Pharmacology +17

Hippo pathway in non-small cell lung cancer: mechanisms, potential targets, and biomarkers

Hongge Liang, Yan Xu, Jing Zhao et al. · Cancer Gene Therapy · 2024 · 37 citations · Full text

Medicine, Cancer Biology, Oncology +17

Characterization of Somatic Mutations That Affect Neoantigens in Non-Small Cell Lung Cancer

Hongge Liang, Yan Xu, Minjiang Chen et al. · Frontiers in Immunology · 2022 · 34 citations · Full text

Medicine, Genetics, Oncology +17

Real‐world data on EGFR/ALK gene status and first‐line targeted therapy rate in newly diagnosed advanced non‐small cell lung cancer patients in Northern China: A prospective observational study

Hongge Liang, Xia Song, Yuhui Zhang et al. · Thoracic Cancer · 2019 · 26 citations · Full text

Medicine, Oncology, Pharmacology +15

Patterns of response in metastatic NSCLC during PD‐1 or PD‐L1 inhibitor therapy: Comparison of the RECIST 1.1 and iRECIST criteria

Hongge Liang, Yan Xu, Minjiang Chen et al. · Thoracic Cancer · 2020 · 24 citations · Full text

Medicine, Oncology, Immunotherapy +16